Penumbra (NYSE:PEN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Penumbra (NYSE:PEN) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Penumbra (NYSE:PEN) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
Penumbra (NYSE:PEN) is now covered by analysts at Wells Fargo & Company. They set an "underweight" rating and a $15.00 price target on the stock.